about
Therapeutic Strategies in HCC: Radiation ModalitiesComparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope.Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors.Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma.Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers.Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.Diagnostic accuracy of low-dose dobutamine echocardiography in predicting post-revascularisation recovery of function in patients with chronic coronary artery disease: relationship to thallium-201 uptake.Prediction of long-term effects of revascularization on regional and global left ventricular function by dobutamine echocardiography and rest Tl-201 imaging alone and in combination in patients with chronic coronary artery disease.Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects.Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment.Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease.Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography.Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique.Correction: modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors.Effects of valsartan on left ventricular diastolic function in patients with mild or moderate essential hypertension: comparison with enalaprilPrediction of improvement in global left ventricular function in patients with chronic coronary artery disease and impaired left ventricular function: rest thallium-201 SPET versus low-dose dobutamine echocardiographyHemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathyRadionuclide monitoring of left ventricular functionEarly and late effects of coronary artery bypass grafting on cardiac haemodynamics during daily physical activities in patients with coronary artery diseaseAssessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteriesEstimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteriesCardiac performance during exercise in hypertensive patients without ventricular hypertrophyNoninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki diseaseEnhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?Gynecologic history: What is the aftermath of a complicated pregnancy?
P50
Q26738658-923CFE5F-DAEF-472E-BF27-C55968628DC9Q33147783-D7029ABC-97FD-41C9-A567-9C7D8B728AE6Q36412543-1CFEFBD1-50D4-4958-8481-1CEED1D0FA07Q36510348-3277430A-E610-40EA-89D9-2D89603FEB53Q37177659-7EC7ED3F-6AF7-4B9D-B1DA-E6BB1BE75709Q42927507-7A013840-E2F5-4EE4-BE7A-E42992E6BE31Q43794920-79E56BE0-E049-416E-B820-ADFD4045481FQ43977899-F63D908C-3900-458B-AC0A-01100D7E53CAQ43984265-E1896E04-642F-4AE0-A64E-3A1571EFCB75Q46634183-79675077-C825-4F45-BA09-0138635B4A80Q46736702-B0758550-C869-455E-A195-B41BB9E03C52Q46777680-8000051C-E133-4BB1-8228-1CE1D98F0549Q46909818-9947DCB4-723C-4C2C-8893-B65D08CC508EQ51164629-7EE636BB-86ED-47E0-8ADB-E0F82730EE53Q51982586-0BC117AE-2BF9-4A0D-8542-4EF9CC4B7DD0Q55340369-56CC4304-89E1-4625-8615-CCF9F84E6398Q73409966-40020820-C30B-4787-AAE6-D38114D6A068Q73466872-04B1DA4A-D8EE-4FA5-AB8F-72036E28319AQ74431173-45D40575-D828-4932-93E8-B7EC8AC78676Q74604337-C417D6A9-8C48-4168-92B1-AADDBB28A78BQ75395589-2176C738-B804-4993-B1F6-3BF74EB0B8E0Q79501862-9B808E4D-FB81-479C-A52D-5FE18AE6B4FFQ80041531-E3BEF6CD-7945-4B62-BA5D-018611F0A537Q83977409-95E14E9C-14F6-45D5-92E9-121F6202F3BFQ84640580-C9ECA634-024A-4926-A032-5987802BFB97Q85091737-4EB188EA-F2DC-448B-A66F-07125D43FF7BQ86500179-6107282D-7A9A-473E-ACAB-B9023B9AF6A4Q88130999-FD73E11A-0770-4E76-AC94-FBD42545E438
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giovanni Storto
@ast
Giovanni Storto
@en
Giovanni Storto
@es
Giovanni Storto
@nl
type
label
Giovanni Storto
@ast
Giovanni Storto
@en
Giovanni Storto
@es
Giovanni Storto
@nl
prefLabel
Giovanni Storto
@ast
Giovanni Storto
@en
Giovanni Storto
@es
Giovanni Storto
@nl
P106
P1153
6602200452
P21
P31
P496
0000-0002-6168-5598